Trial · NCT07891104
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Safety index - incidence of adverse events | 0- 30 minutes/Day 0 to 7 days/Day 0 to 30 days after each dose | Incidence of adverse events after each dose vaccination |
| Primary | Immunogenicity index-Seroconversion rate | Day 30 after basic immunization | The seroconversion rate of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies, and type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after basic immunization |
| Primary | Immunogenicity index-Seropositive rate | Day 30 after basic immunization | The seropositive rate of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies, and type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after basic immunization |
| Primary | Immunogenicity index-Geometric mean concentration (GMC) | Day 30 after basic immunization | The GMC of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies 30 days after basic immunization |
| Primary | Immunogenicity index-Geometric mean titer (GMT) | Day 30 after basic immunization | The GMT of type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after basic immunization |
| Primary | Immunogenicity index-Geometric mean fold increases (GMFI) | Day 30 after basic immunization | The GMFI of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies, and type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after basic immunization |
| Secondary | Safety index - incidence of serious adverse events | From the beginning of the vaccination up to 12 months after the last vaccination completed | Incidence of serious adverse events after vaccination |
| Secondary | Immunogenicity index-Seroconversion rate | Day 30 after booster immunization | The seroconversion rate of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies, and type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after booster immunization |
| Secondary | Immunogenicity index- Seropositive rate | Day 30 after booster immunization | The seropositive rate of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies, and type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after booster immunization |
| Secondary | Immunogenicity index-Geometric mean concentration (GMC) | Day 30 after booster immunization | The GMC of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies 30 days after booster immunization |
| Secondary | Immunogenicity index-Geometric mean titer (GMT) | Day 30 after booster immunization | The GMT of type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after booster immunization |
| Secondary | Immunogenicity index-Geometric mean fold increases (GMFI) | Day 30 after booster immunization | The GMFI of anti-DT, anti-TT, anti-PT, anti-PRN, anti-FHA antibodies, and type I, type II, type III anti-poliovirus neutrilizing antibodies 30 days after booster immunization |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07891104/registered